Metabolomics profiling of the free and total oxidised lipids in urine by LC-MS/MS: application in patients with rheumatoid arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1618-2650
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Metabolomics profiling of the free and total oxidised lipids in urine by LC-MS/MS: application in patients with rheumatoid arthritis ; day:12 ; month:7 ; year:2016 ; pages:1-13
Analytical and bioanalytical chemistry ; (12.7.2016), 1-13
- Creator
-
Fu, Junzeng
- Contributor
-
Schoeman, Johannes C.
Harms, Amy C.
van Wietmarschen, Herman A.
Vreeken, Rob J.
BERGER, RUUD
Cuppen, Bart V. J.
Lafeber, Floris P. J. G.
van der Greef, Jan
Hankemeier, Thomas
SpringerLink (Online service)
- DOI
-
10.1007/s00216-016-9742-2
- URN
-
urn:nbn:de:1111-20160719262
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fu, Junzeng
- Schoeman, Johannes C.
- Harms, Amy C.
- van Wietmarschen, Herman A.
- Vreeken, Rob J.
- BERGER, RUUD
- Cuppen, Bart V. J.
- Lafeber, Floris P. J. G.
- van der Greef, Jan
- Hankemeier, Thomas
- SpringerLink (Online service)
Other Objects (12)
Drosophila ecdysteroidome by LC-MS/MS
Untargeted LC–MS/MS analysis reveals metabolomics feature of osteosarcoma stem cell response to methotrexate
Inferring serum proteolytic activity from LC-MS/MS data
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Method development for the analysis of bioactive lipids by liquid chromatography tandem mass spectrometry (LC-MS-MS)
Optimal precursor ion selection for LC-MS/MS based proteomics
Visualization of LC‐MS/MS proteomics data in MaxQuant
Optimal precursor ion selection for LC-MS/MS based proteomics
Interrogating data-independent acquisition LC–MS/MS for affinity proteomics
LC-MS/MS based metabolomics and proteomics reveal candidate biomarkers and molecular mechanism of early IgA nephropathy
Steroid hormone analysis via LC-MS/MS in clinical routine diagnostics
Drosophila ecdysteroidome by LC-MS/MS
Untargeted LC–MS/MS analysis reveals metabolomics feature of osteosarcoma stem cell response to methotrexate
Inferring serum proteolytic activity from LC-MS/MS data
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Method development for the analysis of bioactive lipids by liquid chromatography tandem mass spectrometry (LC-MS-MS)
Optimal precursor ion selection for LC-MS/MS based proteomics
Visualization of LC‐MS/MS proteomics data in MaxQuant
Optimal precursor ion selection for LC-MS/MS based proteomics
Interrogating data-independent acquisition LC–MS/MS for affinity proteomics
LC-MS/MS based metabolomics and proteomics reveal candidate biomarkers and molecular mechanism of early IgA nephropathy
Steroid hormone analysis via LC-MS/MS in clinical routine diagnostics
Drosophila ecdysteroidome by LC-MS/MS
Untargeted LC–MS/MS analysis reveals metabolomics feature of osteosarcoma stem cell response to methotrexate
Inferring serum proteolytic activity from LC-MS/MS data
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Method development for the analysis of bioactive lipids by liquid chromatography tandem mass spectrometry (LC-MS-MS)
Optimal precursor ion selection for LC-MS/MS based proteomics
Visualization of LC‐MS/MS proteomics data in MaxQuant
Optimal precursor ion selection for LC-MS/MS based proteomics
Interrogating data-independent acquisition LC–MS/MS for affinity proteomics
LC-MS/MS based metabolomics and proteomics reveal candidate biomarkers and molecular mechanism of early IgA nephropathy